About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Leukemia Drug To Kill Cancerous Cells Alone

by Gopalan on May 4, 2011 at 6:13 AM
Font : A-A+

 New Leukemia Drug To Kill Cancerous Cells Alone

A new experimental drug could be successful in killing only the malignant B lymphocytes, which cause chronic lymphocytic leukemia (CLL).

Available leukemia drugs do not stop with the cancerous cells alone, but go on to destroy T lymphocytes too. A lymphocyte is a type of white blood cell in the vertebrate immune system. Small lymphocytes consist of T cells and B cells. T cells (Thymus cells) and B cells (bone cells) are the major cellular components of the adaptive immune response.

Advertisement

When CLL treatment destroys T lymphocytes along with the cancerous B lymphocytes, patients become highly susceptible to life-threatening infections.

A new study by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James shows that the experimental agent PCI-32765 selectively kills the cancerous cells alone. The findings have been published online in the journal Blood.
Advertisement

 "A drug that kills malignant B lymphocytes and spares T lymphocytes could dramatically improve outcomes for CLL patients," says study leader Dr. John C. Byrd, director, division of hematology and professor of medicine, of medicinal chemistry and of veterinary biosciences at the OSUCCC — James.

"Our collective results indicate that PCI-32765 is an outstanding candidate for further development as a therapeutic for CLL," says study co-director Dr. Amy J. Johnson, assistant professor of hematology and medicinal chemistry, and a CLL researcher with the OSUCCC-James.

The research by Byrd, Johnson and a group of colleagues used CLL cells from ten patients. It had several key findings related to PCI-32765:

The agent specifically targets an important signaling molecule called Bruton's tyrosine kinase, which is overexpressed in CLL cells and absent in T cells.

The agent inhibits the proliferation of CLL cells in laboratory culture and promotes their death by self-destruction (apoptosis).

It blocks survival signals from cells in the surrounding microenvironment, including soluble factors such as IL-6, IL-4, and TNF-á, and stromal-cell contact.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 9 Reasons Why We Should Practice Kindness
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Leukemia Parkinsons Disease Surgical Treatment Ganglion Cysts - Ganglion Wrist Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Signature Drug Toxicity Multiple Myeloma Bone Marrow Transplantation 

Most Popular on Medindia

The Essence of Yoga Blood - Sugar Chart Drug Side Effects Calculator Sinopril (2mg) (Lacidipine) How to Reduce School Bag Weight - Simple Tips Diaphragmatic Hernia A-Z Drug Brands in India Loram (2 mg) (Lorazepam) Vent Forte (Theophylline) Indian Medical Journals

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use